title: Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine.
authors.affiliation: Division of Pediatric Infectious Diseases, Children's Hospital of Pittsburgh, PA 15213, USA.
authors.forename: Philana Ling
authors.initials: PL
authors.lastname: Lin
authors.forename: Marian G
authors.initials: MG
authors.lastname: Michaels
authors.forename: Janine
authors.initials: J
authors.lastname: Janosky
authors.forename: Michelene
authors.initials: M
authors.lastname: Ortenzo
authors.forename: Ellen R
authors.initials: ER
authors.lastname: Wald
authors.forename: Edward O
authors.initials: EO
authors.lastname: Mason
mesh_terms: D002675:Child, Preschool; D005260:Female; D006776:Hospitals, Pediatric; D006785:Hospitals, University; D006801:Humans; D017589:Immunization Programs / Q000331:legislation & jurisprudence; D015994:Incidence; D007223:Infant; D008004:Licensure; D008297:Male; D011008:Pneumococcal Infections / Q000134:cerebrospinal fluid / Q000453:epidemiology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D011018:Pneumonia, Pneumococcal / Q000134:cerebrospinal fluid / Q000453:epidemiology* / Q000517:prevention & control*; D012017:Referral and Consultation; D018805:Sepsis / Q000453:epidemiology / Q000517:prevention & control; D018074:Vaccines, Conjugate / Q000627:therapeutic use
chemical_list: D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate